AZD0901 targets CLDN18.2 on the cell surface; after internalization, the linker is cleaved and MMAE binds beta‑tubulin to disrupt microtubules, causing G2/M arrest and apoptosis in CLDN18.2‑positive cells. Beta‑tubulin itself is not the targeting determinant.